SH5-07 (SH-5-07) CAS:1456632-41-9
SH5-07 (SH-5-07)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1704 | 50mg | 335.00 | + Add to cart |
|
| R-C-1704 | 100mg | 600.00 | + Add to cart |
|
| R-C-1704 | 250mg | 980.00 | + Add to cart |
|
|
|
||||
Product description
SH5-07 is a robust hydroxamic acid-based STAT3 inhibitor,which induce antitumor cell effects in vitro and antitumor response in vivo against human glioma and breast cancer models.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---SH5-07 (SH-5-07)
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


